Hematologic Tests
7
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Clinical Evaluation of Precision for the Potassium and Ionized Calcium Tests in Capillary Specimens
Evaluation of Potassium (K) and Ionized Calcium (iCa) Tests Using Capillary Specimens
Interval Training and Plasma Volume Variation
Clinical Evaluation of the iMOST-X1 Hematology Analyzer - Matrix Study
Prospective Screening Programme for Malignant Tumors
Testing the Effect of Whole-wheat Sourdough Bread Compared to White Bread on Healthy Individuals
Risk Stratification in Acutely Admitted Medical Patients